Pathogenesis of hepatitis B virus infection
- PMID: 17206757
- PMCID: PMC4065880
- DOI: 10.3748/wjg.v13.i1.82
Pathogenesis of hepatitis B virus infection
Abstract
Infection with hepatitis B virus (HBV) leads to a wide spectrum of clinical presentations ranging from an asymptomatic carrier state to self-limited acute or fulminant hepatitis to chronic hepatitis with progression to cirrhosis and hepatocellular carcinoma. Infection with HBV is one of the most common viral diseases affecting man. Both viral factors as well as the host immune response have been implicated in the pathogenesis and clinical outcome of HBV infection. In this review, we will discuss the impact of virus-host interactions for the pathogenesis of HBV infection and liver disease. These interactions include the relevance of naturally occurring viral variants for clinical disease, the role of virus-induced apoptosis for HBV-induced liver cell injury and the impact of antiviral immune responses for outcome of infection.
Figures
Similar articles
-
Genetic variants of hepatitis B virus and their clinical relevance.Minerva Gastroenterol Dietol. 2005 Mar;51(1):95-108. Minerva Gastroenterol Dietol. 2005. PMID: 15756149 Review.
-
Viral determinants and host immune responses in the pathogenesis of HBV infection.J Med Virol. 2002 Jul;67(3):454-7. doi: 10.1002/jmv.10096. J Med Virol. 2002. PMID: 12116045 Review.
-
Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.Virology. 1998 Apr 25;244(1):146-60. doi: 10.1006/viro.1998.9079. Virology. 1998. PMID: 9581787
-
Hepatitis B virus pre-S/S variants in liver diseases.World J Gastroenterol. 2018 Apr 14;24(14):1507-1520. doi: 10.3748/wjg.v24.i14.1507. World J Gastroenterol. 2018. PMID: 29662289 Free PMC article. Review.
-
NIH consensus development statement on management of hepatitis B.NIH Consens State Sci Statements. 2008 Oct 22-24;25(2):1-29. NIH Consens State Sci Statements. 2008. PMID: 18949020
Cited by
-
Identification of antibodies cross-reactive with woodchuck immune cells and activation of virus-specific and global cytotoxic T cell responses by anti-PD-1 and anti-PD-L1 in experimental chronic hepatitis B and persistent occult hepadnaviral infection.Front Microbiol. 2022 Dec 6;13:1011070. doi: 10.3389/fmicb.2022.1011070. eCollection 2022. Front Microbiol. 2022. PMID: 36560951 Free PMC article.
-
Mutations of Basal core promoter and precore regions in hepatitis B virus genotypes B and C.Hepat Mon. 2014 Dec 28;15(1):e23034. doi: 10.5812/hepatmon.23034. eCollection 2015 Jan. Hepat Mon. 2014. PMID: 25741368 Free PMC article.
-
Liver Disease: Induction, Progression, Immunological Mechanisms, and Therapeutic Interventions.Int J Mol Sci. 2021 Jun 24;22(13):6777. doi: 10.3390/ijms22136777. Int J Mol Sci. 2021. PMID: 34202537 Free PMC article. Review.
-
Progress towards a needle-free hepatitis B vaccine.Pharm Res. 2011 May;28(5):986-1012. doi: 10.1007/s11095-010-0314-4. Epub 2010 Nov 19. Pharm Res. 2011. PMID: 21088986 Review.
-
Comparative evaluation of INNO-LiPA HBV assay, direct DNA sequencing and subtractive PCR-RFLP for genotyping of clinical HBV isolates.Virol J. 2010 May 30;7:111. doi: 10.1186/1743-422X-7-111. Virol J. 2010. PMID: 20509964 Free PMC article.
References
-
- Nassal M. Hepatitis B virus replication: novel roles for virus-host interactions. Intervirology. 1999;42:100–116. - PubMed
-
- Hollinger FB, Liang TJ. Hepatitis B virus. In: Knipe DM, Howley PM, editors. Fields Virology. Philadelphia: Lippincott Williams and Wilkins; 2001. pp. 2971–3036.
-
- Summers J, Mason WS. Replication of the genome of a hepatitis B--like virus by reverse transcription of an RNA intermediate. Cell. 1982;29:403–415. - PubMed
-
- Feld J, Locarnini S. Antiviral therapy for hepatitis B virus infections: new targets and technical challenges. J Clin Virol. 2002;25:267–283. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical